Celldex Therapeutics
CLDX
#5055
Rank
$1.38 B
Marketcap
$20.82
Share price
3.79%
Change (1 day)
-39.93%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2025 (TTM): -$0.22 Billion USD

According to Celldex Therapeutics's latest financial reports the company's current earnings are $7.55 Million USD. In 2024 the company made an earning of -$0.2 Billion USD a decrease over its 2023 earnings that were of -$0.15 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.22 Billion11.34%
2024 -$0.2 Billion37.34%
2023 -$0.15 Billion32.63%
2022 -$0.11 Billion54.88%
2021 -$69.15 Million39.49%
2020 -$49.58 Million-9.08%
2019 -$54.53 Million-28.64%
2018 -$76.41 Million-30.11%
2017 -$0.11 Billion-17.75%
2016 -$0.14 Billion4.5%
2015 -$0.13 Billion4.09%
2014 -$0.13 Billion51.57%
2013 -$80.63 Million40.1%
2012 -$57.55 Million
2010 -$1.25 Million-96.59%
2009 -$36.61 Million
2006 -$22.37 Million
2004 -$13.59 Million15.75%
2003 -$11.74 Million-18.69%
2002 -$14.44 Million-41.22%
2001 -$24.56 Million59%
2000 -$15.45 Million27.65%
1999 -$12.1 Million53.12%
1998 -$7.9 Million2.6%
1997 -$7.7 Million-33.62%
1996 -$11.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-$0.8 Billion 263.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-$94.24 Million-56.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-$0.9 Million-99.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$6.65 B-3,161.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$10.34 B-4,860.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$5.41 B-2,591.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-$4.21 Million-98.06%๐Ÿ‡บ๐Ÿ‡ธ USA